Performa LTD (Us), LLC Maravai Lifesciences Holdings, Inc. Transaction History

Performa LTD (Us), LLC

$284 Million
Q4 2024

A detailed history of Performa LTD (Us), LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Performa LTD (Us), LLC holds 5,000 shares of MRVI stock, worth $14,050. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,000

Previous 700 614.29%

Holding current value

$14,050

Previous $5,000 440.0%

% of portfolio

0.01%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$4.42 - $8.5 $19,006 - $36,550	4,300 Added 614.29%	5,000 $27,000
Q3 2024 Nov 14, 2024	BUY	$6.84 - $9.73 $3,078 - $4,378	450 Added 180.0%	700 $5,000
Q2 2024 Aug 12, 2024	SELL	$6.87 - $11.34 $44,655 - $73,710	-6,500 Reduced 96.3%	250 $1,000
Q1 2024 May 10, 2024	BUY	$5.11 - $8.76 $3,832 - $6,570	750 Added 12.5%	6,750 $58,000
Q4 2023 Feb 06, 2024	BUY	$4.7 - $9.87 $14,922 - $31,337	3,175 Added 112.39%	6,000 $39,000
Q3 2023 Nov 01, 2023	BUY	$9.14 - $12.85 $7,540 - $10,601	825 Added 41.25%	2,825 $28,000
Q2 2023 Aug 04, 2023	BUY	$12.09 - $15.0 $2,418 - $3,000	200 Added 11.11%	2,000 $24,000
Q1 2023 May 01, 2023	BUY	$12.99 - $16.48 $3,897 - $4,944	300 Added 20.0%	1,800 $25,000
Q4 2022 Feb 03, 2023	BUY	$12.5 - $24.78 $15,625 - $30,975	1,250 Added 500.0%	1,500 $21,000
Q3 2022 Nov 09, 2022	BUY	$20.6 - $30.37 $4,120 - $6,074	200 Added 400.0%	250 $6,000
Q2 2022 Aug 02, 2022	BUY	$26.05 - $37.48 $1,302 - $1,873	50 New	50 $1,000

Others Institutions Holding MRVI

# of Institutions

203

Shares Held

138M

Call Options Held

271K

Put Options Held

37.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $370M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Performa LTD (Us), LLC, based on Form 13F filings with the SEC.

News

Stay updated on Performa LTD (Us), LLC with notifications on news.

Account

Performa LTD (Us), LLC Maravai Lifesciences Holdings, Inc. Transaction History